LEMAITRE VASCULAR INC (LMAT) Stock Fundamental Analysis
USA - NASDAQ:LMAT - US5255582018 - Common Stock
92.45 USD
+0.08 (+0.09%)
92.45 USD
0 (0%)
Overall LMAT gets a fundamental rating of 7 out of 10. We evaluated LMAT against 191 industry peers in the Health Care Equipment & Supplies industry. LMAT has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. LMAT has a decent growth rate and is not valued too expensively. This makes LMAT very considerable for quality investing!
1. Profitability
1.1 Basic Checks
In the past year LMAT was profitable.
LMAT had a positive operating cash flow in the past year.
In the past 5 years LMAT has always been profitable.
In the past 5 years LMAT always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 8.16%, LMAT belongs to the best of the industry, outperforming 91.62% of the companies in the same industry.
LMAT's Return On Equity of 12.99% is amongst the best of the industry. LMAT outperforms 89.53% of its industry peers.
LMAT has a Return On Invested Capital of 7.70%. This is amongst the best in the industry. LMAT outperforms 84.82% of its industry peers.
The Average Return On Invested Capital over the past 3 years for LMAT is in line with the industry average of 8.46%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.16% | ||
| ROE | 12.99% | ||
| ROIC | 7.7% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
1.3 Margins
LMAT's Profit Margin of 20.08% is amongst the best of the industry. LMAT outperforms 93.72% of its industry peers.
In the last couple of years the Profit Margin of LMAT has grown nicely.
With an excellent Operating Margin value of 23.34%, LMAT belongs to the best of the industry, outperforming 93.72% of the companies in the same industry.
LMAT's Operating Margin has improved in the last couple of years.
The Gross Margin of LMAT (69.11%) is better than 77.49% of its industry peers.
In the last couple of years the Gross Margin of LMAT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.34% | ||
| PM (TTM) | 20.08% | ||
| GM | 69.11% |
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
2. Health
2.1 Basic Checks
LMAT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, LMAT has more shares outstanding
LMAT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, LMAT has a worse debt to assets ratio.
2.2 Solvency
LMAT has an Altman-Z score of 7.78. This indicates that LMAT is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 7.78, LMAT belongs to the best of the industry, outperforming 88.48% of the companies in the same industry.
LMAT has a debt to FCF ratio of 3.21. This is a good value and a sign of high solvency as LMAT would need 3.21 years to pay back of all of its debts.
LMAT has a Debt to FCF ratio of 3.21. This is amongst the best in the industry. LMAT outperforms 86.91% of its industry peers.
LMAT has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.46, LMAT perfoms like the industry average, outperforming 42.93% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.46 | ||
| Debt/FCF | 3.21 | ||
| Altman-Z | 7.78 |
ROIC/WACC0.91
WACC8.5%
2.3 Liquidity
A Current Ratio of 13.96 indicates that LMAT has no problem at all paying its short term obligations.
LMAT's Current ratio of 13.96 is amongst the best of the industry. LMAT outperforms 98.43% of its industry peers.
A Quick Ratio of 11.74 indicates that LMAT has no problem at all paying its short term obligations.
The Quick ratio of LMAT (11.74) is better than 95.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 13.96 | ||
| Quick Ratio | 11.74 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 23.35% over the past year.
LMAT shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.13% yearly.
LMAT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.11%.
LMAT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.41% yearly.
EPS 1Y (TTM)23.35%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%15.38%
Revenue 1Y (TTM)14.11%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%15.01%
3.2 Future
LMAT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.76% yearly.
LMAT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.67% yearly.
EPS Next Y20.02%
EPS Next 2Y14.31%
EPS Next 3Y13.26%
EPS Next 5Y9.76%
Revenue Next Year13.91%
Revenue Next 2Y11.23%
Revenue Next 3Y11.24%
Revenue Next 5Y9.67%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 44.88, the valuation of LMAT can be described as expensive.
Based on the Price/Earnings ratio, LMAT is valued a bit cheaper than 69.63% of the companies in the same industry.
When comparing the Price/Earnings ratio of LMAT to the average of the S&P500 Index (27.20), we can say LMAT is valued expensively.
With a Price/Forward Earnings ratio of 36.47, LMAT can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LMAT indicates a somewhat cheap valuation: LMAT is cheaper than 70.68% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.71, LMAT is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.88 | ||
| Fwd PE | 36.47 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, LMAT is valued a bit cheaper than the industry average as 72.25% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of LMAT indicates a somewhat cheap valuation: LMAT is cheaper than 77.49% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 40.01 | ||
| EV/EBITDA | 25.43 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates LMAT does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of LMAT may justify a higher PE ratio.
LMAT's earnings are expected to grow with 13.26% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.24
PEG (5Y)2.62
EPS Next 2Y14.31%
EPS Next 3Y13.26%
5. Dividend
5.1 Amount
With a yearly dividend of 0.85%, LMAT is not a good candidate for dividend investing.
LMAT's Dividend Yield is rather good when compared to the industry average which is at 1.69. LMAT pays more dividend than 91.62% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, LMAT's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.85% |
5.2 History
On average, the dividend of LMAT grows each year by 13.60%, which is quite nice.
LMAT has paid a dividend for at least 10 years, which is a reliable track record.
LMAT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)13.6%
Div Incr Years13
Div Non Decr Years13
5.3 Sustainability
34.45% of the earnings are spent on dividend by LMAT. This is a low number and sustainable payout ratio.
LMAT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP34.45%
EPS Next 2Y14.31%
EPS Next 3Y13.26%
92.45
+0.08 (+0.09%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners95.69%
Inst Owner Change-2.07%
Ins Owners8.54%
Ins Owner Change-9.35%
Market Cap2.09B
Analysts78.82
Price Target106.87 (15.6%)
Short Float %6.46%
Short Ratio8.39
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.85% |
Yearly Dividend0.64
Dividend Growth(5Y)13.6%
DP34.45%
Div Incr Years13
Div Non Decr Years13
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.86%
Min EPS beat(2)-5.52%
Max EPS beat(2)3.81%
EPS beat(4)2
Avg EPS beat(4)1.56%
Min EPS beat(4)-5.52%
Max EPS beat(4)10.44%
EPS beat(8)6
Avg EPS beat(8)4.62%
EPS beat(12)8
Avg EPS beat(12)3.08%
EPS beat(16)8
Avg EPS beat(16)-1.76%
Revenue beat(2)2
Avg Revenue beat(2)1.31%
Min Revenue beat(2)0.79%
Max Revenue beat(2)1.83%
Revenue beat(4)3
Avg Revenue beat(4)0.17%
Min Revenue beat(4)-2.38%
Max Revenue beat(4)1.83%
Revenue beat(8)4
Avg Revenue beat(8)-0.31%
Revenue beat(12)6
Avg Revenue beat(12)-0.07%
Revenue beat(16)7
Avg Revenue beat(16)-0.44%
PT rev (1m)0.27%
PT rev (3m)0.27%
EPS NQ rev (1m)0.97%
EPS NQ rev (3m)5.28%
EPS NY rev (1m)6%
EPS NY rev (3m)5.34%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)2.15%
Revenue NY rev (1m)2.14%
Revenue NY rev (3m)2.14%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.88 | ||
| Fwd PE | 36.47 | ||
| P/S | 8.92 | ||
| P/FCF | 40.01 | ||
| P/OCF | 35.62 | ||
| P/B | 5.77 | ||
| P/tB | 7.94 | ||
| EV/EBITDA | 25.43 |
EPS(TTM)2.06
EY2.23%
EPS(NY)2.53
Fwd EY2.74%
FCF(TTM)2.31
FCFY2.5%
OCF(TTM)2.6
OCFY2.81%
SpS10.36
BVpS16.02
TBVpS11.64
PEG (NY)2.24
PEG (5Y)2.62
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.16% | ||
| ROE | 12.99% | ||
| ROCE | 10.02% | ||
| ROIC | 7.7% | ||
| ROICexc | 18.52% | ||
| ROICexgc | 32.83% | ||
| OM | 23.34% | ||
| PM (TTM) | 20.08% | ||
| GM | 69.11% | ||
| FCFM | 22.3% |
ROA(3y)7.77%
ROA(5y)8.17%
ROE(3y)10.28%
ROE(5y)10.74%
ROIC(3y)8.26%
ROIC(5y)8.93%
ROICexc(3y)14.32%
ROICexc(5y)13.54%
ROICexgc(3y)28.83%
ROICexgc(5y)29.82%
ROCE(3y)10.75%
ROCE(5y)11.62%
ROICexcg growth 3Y-0.4%
ROICexcg growth 5Y7.52%
ROICexc growth 3Y9.22%
ROICexc growth 5Y8.43%
OM growth 3Y0.27%
OM growth 5Y5.61%
PM growth 3Y4.76%
PM growth 5Y5.57%
GM growth 3Y1.48%
GM growth 5Y0.13%
F-Score5
Asset Turnover0.41
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.46 | ||
| Debt/FCF | 3.21 | ||
| Debt/EBITDA | 2.59 | ||
| Cap/Depr | 63.73% | ||
| Cap/Sales | 2.74% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 90.57% | ||
| Profit Quality | 111.05% | ||
| Current Ratio | 13.96 | ||
| Quick Ratio | 11.74 | ||
| Altman-Z | 7.78 |
F-Score5
WACC8.5%
ROIC/WACC0.91
Cap/Depr(3y)60.87%
Cap/Depr(5y)52.43%
Cap/Sales(3y)2.97%
Cap/Sales(5y)2.88%
Profit Quality(3y)96.62%
Profit Quality(5y)110.46%
High Growth Momentum
Growth
EPS 1Y (TTM)23.35%
EPS 3Y15.47%
EPS 5Y17.13%
EPS Q2Q%15.38%
EPS Next Y20.02%
EPS Next 2Y14.31%
EPS Next 3Y13.26%
EPS Next 5Y9.76%
Revenue 1Y (TTM)14.11%
Revenue growth 3Y12.5%
Revenue growth 5Y13.41%
Sales Q2Q%15.01%
Revenue Next Year13.91%
Revenue Next 2Y11.23%
Revenue Next 3Y11.24%
Revenue Next 5Y9.67%
EBIT growth 1Y20%
EBIT growth 3Y12.81%
EBIT growth 5Y19.77%
EBIT Next Year37.11%
EBIT Next 3Y21.1%
EBIT Next 5YN/A
FCF growth 1Y176.09%
FCF growth 3Y7.14%
FCF growth 5Y28.96%
OCF growth 1Y129.52%
OCF growth 3Y7.93%
OCF growth 5Y25.49%